NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

罕見疾病遺傳基因檢驗的全球市場 (各疾病類型·各技術·各專業領域·各最終用途·各地區):市場佔有率·規模·趨勢分析與未來預測 (2020年∼2027年)

Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type ; By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 - 2027

出版商 Polaris Market Research 商品編碼 986413
出版日期 內容資訊 英文 127 Pages
商品交期: 最快1-2個工作天內
價格
罕見疾病遺傳基因檢驗的全球市場 (各疾病類型·各技術·各專業領域·各最終用途·各地區):市場佔有率·規模·趨勢分析與未來預測 (2020年∼2027年) Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type ; By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 - 2027
出版日期: 2020年12月01日內容資訊: 英文 127 Pages
簡介

全球罕見疾病遺傳基因檢驗的市場規模在2027年前將達到18億美元。作為市場主要促進因素,罕見疾病的即時檢測需求增加,及罕見疾病的盛行率的上升,基因檢驗技術的進步,成本效率性高(貴)的治療方法愈來愈受重視,各國政府的輔助政策等能取得。

本報告提供全球罕見疾病的遺傳基因檢驗的市場相關分析,彙整技術概要和市場基本結構,主要的推動及阻礙市場要素,產業的向心力,整體市場規模趨勢預測 (金額·以數量為準,過去4年·今後8年份),各疾病類型·各技術·各專業領域·各最終用途·各地區的詳細趨勢,主要企業的簡介等資訊,為您概述為以下內容。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 罕見疾病遺傳基因檢驗市場考察

  • 罕見疾病遺傳基因檢驗:產業的概要
  • 罕見疾病遺傳基因檢驗市場動態
    • 推動要素和機會
    • 阻礙因素與課題
  • 波特的五力分析
  • 大環境分析
  • 罕見疾病遺傳基因檢驗市場:產業趨勢

第5章 罕見疾病遺傳基因檢驗市場:疾病的種類分別分析

  • 分析的要點
  • 簡介
    • 市場規模:各疾病類型 (以金額為準,2016年∼2027年)
  • 神經病變
    • 市場規模:各地區 (以金額為準,2016年∼2027年)
  • 免疫力缺乏
  • 造血系疾病
  • 內分泌·代謝性疾病
  • 癌症
  • 肌肉骨骼系統障礙
  • 心血管障礙
  • 皮膚科疾病
  • 其他罕見疾病

第6章 罕見疾病遺傳基因檢驗市場:各技術分析

  • 分析的要點
  • 簡介
    • 市場規模:各技術 (以金額為準,2016年∼2027年)
  • 次世代定序 (NGS)
    • 全EXOME序列 (WES)
    • 全基因序列 (WGS)
  • 陣列技術
  • PCR檢驗
  • FISH
  • Sanger定序
  • 染色體組型分析

第7章 罕見疾病遺傳基因檢驗市場:各專業領域分析

  • 分析的要點
  • 簡介
    • 市場規模:各專業領域 (以金額為準,2016年∼2027年)
  • 分子遺傳基因檢驗
  • 染色體遺傳基因檢驗
  • 生物化學的遺傳基因檢驗

第8章 罕見疾病遺傳基因檢驗市場:各最終用途分析

  • 分析的要點
  • 簡介
    • 市場規模:各最終用途 (以金額為準,2016年∼2027年)
  • 研究機關·CRO (醫藥品開發受託機關)
  • 醫院·診所
  • 診斷檢驗室

第9章 罕見疾病遺傳基因檢驗市場:各地區的分析

  • 分析的要點
  • 簡介
    • 市場規模:各地區 (以金額為準,2016年∼2027年)
  • 北美的罕見疾病遺傳基因檢驗市場
    • 市場規模:各疾病類型 (以金額為準,2016年∼2027年)
    • 市場規模:各技術 (以金額為準,2016年∼2027年)
    • 市場規模:各專業領域 (以金額為準,2016年∼2027年)
    • 市場規模:各最終用途 (以金額為準,2016年∼2027年)
    • 美國
    • 加拿大
  • 歐洲的罕見疾病遺傳基因檢驗市場
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 奧地利
  • 亞太地區的罕見疾病遺傳基因檢驗市場
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國 (UAE)
    • 以色列
    • 南非
  • 南美的罕見疾病遺傳基因檢驗市場
    • 墨西哥
    • 巴西
    • 阿根廷

第10章 競爭情形

  • 事業擴張·企業收購分析
  • 事業聯盟·合作,契約,展示會

第11章 企業簡介

  • Strand Life Sciences
  • Myriad Genetics
  • Quest Diagnostics Inc.
  • Centogene N.V.
  • Invitae Corporation
  • Eurofins Scientific
  • Ambry Genetics
  • Macrogen, Inc.
  • Health Network Laboratories
  • Fulgent Genetics Inc.
目錄
Product Code: PM1772

Title:
Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Ailments, Endocrine & Metabolism Disorders, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disorders, Others); By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 - 2027.

The global rare disease genetic testing market size is expected to reach USD 1.8 Billion by 2027 according to a new study by Polaris Market Research. The report "Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Ailments, Endocrine & Metabolism Disorders, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disorders, Others); By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 - 2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing need for on-time diagnosis of uncommon disorders, rising prevalence of rare disorders, innovations in genomic testing, and the focused approach of the market player's in cost-effective treatments are the key factors responsible for market growth. Moreover, government-sponsored schemes are also expected to positively impact the market. In February 2020, the government of India announced financial assistance of INR 15 lacs to the patients suffering from uncommon ailments under the Rashtriya Arogaya Nidhi scheme for a one-time treatment.

The global rare disease genetic testing industry is fragmented based on disease type, technology, specialty, end-use, and region. In terms of disease type, the market is segmented into neurological disorders, immunological disorders, hematology illnesses, endocrine & metabolism ailments, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology illnesses, and others.

Based on technology, the rare disease genetic testing industry is further bifurcated into next-generation sequencing, array technology, PCR-based testing, FISH, sanger sequencing, and karyotyping. Based on specialty, the rare disease genetic testing industry is further bifurcated into molecular, chromosomal, and biochemical genomic tests. Based on end-use, the rare disease genomic testing industry is further bifurcated into research laboratories & CROs, hospitals & clinics, and diagnostic laboratories.

Segment Highlights

Neurological ailments accounted for the largest revenue share in 2019 on account of the increasing prevalence of neurologic disorders across the globe and presence of numerous testing techniques

Based on technology, the next generation sequencing segment is projected to constitute almost half of the market in 2027. The usage of the technology in whole genome sequencing is the key factor responsible for its segment's growth.

Molecular tests are expected to account for the highest revenue share by the end of 2027. The availability of advanced technologies and ability to test ultra-rare disorders is expected to drive market growth.

Research laboratories & CROs accounted for the largest revenue share in 2019 owing to the increasing number of tests and growing occurrence of rare disorders across the developed economies

List of Key Players:

Strand Life Sciences

Myriad Genetics

Quest Diagnostics Inc.

Centogene N.V.

Invitae Corporation

Baylor Genetics

Ambry Genetics

Macrogen, Inc.

Opko Health, Inc.

Color Genomics, Inc.

Health Network Laboratories

Preventiongenetics, Progenity, Inc.

Fulgent Genetics Inc.

Others

Polaris Market Research has segmented the rare disease genetic testing market report on the basis of disease type, technology, specialty, end-use, and region

Rare Disease Genetic Testing, Disease Type Outlook (Revenue - USD Million, 2016 - 2027)

Neurological Disorders

Immunological Disorders

Hematology Ailments

Endocrine & Metabolism Disorders

Cancer

Musculoskeletal Disorders

Cardiovascular Disorders

Dermatology Disorders

Others

Rare Disease Genetic Testing, Technology Outlook (Revenue - USD Million, 2016 - 2027)

Next Generation Sequencing

Whole Exome Sequencing

Whole Genome Sequencing

Array Technology

PCR-based Testing

FISH

Sanger Sequencing

Karyotyping

Rare Disease Genetic Testing, Specialty Outlook (Revenue - USD Million, 2016 - 2027)

Molecular Genetic Tests

Chromosomal Genetic Tests

Biochemical Genetic Tests

Rare Disease Genetic Testing, Technology Outlook (Revenue - USD Million, 2016 - 2027)

Research Laboratories & CROs

Hospitals & Clinics

Diagnostic Laboratories

Rare Disease Genetic Testing, Regional Outlook (Revenue - USD Million, 2016 - 2027)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Rare Disease Genetic Testing Market Insights

  • 4.1. Rare Disease Genetic Testing - Industry snapshot
  • 4.2. Rare Disease Genetic Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Prevalence of rare diseases
      • 4.2.1.2. Government backed funding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of epidemiological data
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Rare Disease Genetic Testing Market Industry trends

5. Rare Disease Genetic Testing Market Assessment by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Rare Disease Genetic Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • 5.3. Neurological Disorders
    • 5.3.1. Global Rare Disease Genetic Testing Market, by Neurological Disorders, by Region, 2016- 2027 (USD Million)
  • 5.4. Immunological Disorders
    • 5.4.1. Global Rare Disease Genetic Testing Market, by Immunological Disorders, by Region, 2016- 2027 (USD Million)
  • 5.5. Hematology Diseases
    • 5.5.1. Global Rare Disease Genetic Testing Market, by Hematology Diseases, by Region, 2016- 2027 (USD Million)
  • 5.6. Endocrine & Metabolism Diseases
    • 5.6.1. Global Rare Disease Genetic Testing Market, by Endocrine & Metabolism Diseases, by Region, 2016- 2027 (USD Million)
  • 5.7. Cancer
    • 5.7.1. Global Rare Disease Genetic Testing Market, by Cancer, by Region, 2016- 2027 (USD Million)
  • 5.8. Musculoskeletal Disorders
    • 5.8.1. Global Rare Disease Genetic Testing Market, by Musculoskeletal Disorders, by Region, 2016- 2027 (USD Million)
  • 5.9. Cardiovascular Disorders
    • 5.9.1. Global Rare Disease Genetic Testing Market, by Cardiovascular Disorders, by Region, 2016- 2027 (USD Million)
  • 5.10. Dermatology Diseases
    • 5.10.1. Global Rare Disease Genetic Testing Market, by Dermatology Diseases, by Region, 2016- 2027 (USD Million)
  • 5.11. Other Rare Diseases
    • 5.11.1. Global Rare Disease Genetic Testing Market, by Other Rare Diseases, by Region, 2016- 2027 (USD Million)

6. Global Rare Disease Genetic Testing Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Rare Disease Genetic Testing Market, By Technology, 2016 - 2027 (USD Million)
  • 6.3. Next Generation Sequencing
    • 6.3.1. Global Rare Disease Genetic Testing Market, by Next Generation Sequencing, By Region, 2016- 2027 (USD Million)
    • 6.3.2. Whole Exome Sequencing
      • 6.3.2.1. Whole Exome Sequencing Market, By Region, 2016- 2027 (USD Million)
    • 6.3.3. Whole Genome Sequencing
      • 6.3.3.1. Whole Genome Sequencing Market, By Region, 2016- 2027 (USD Million
  • 6.4. Array Technology
    • 6.4.1. Global Rare Disease Genetic Testing Market, by Array Technology, by Region, 2016- 2027 (USD Million)
  • 6.5. PCR - based Testing
    • 6.5.1. Global Rare Disease Genetic Testing Market, by PCR - based Testing, by Region, 2016- 2027 (USD Million)
  • 6.6. FISH
    • 6.6.1. Global Rare Disease Genetic Testing Market, by FISH, by Region, 2016- 2027 (USD Million)
  • 6.7. Sanger Sequencing
    • 6.7.1. Global Rare Disease Genetic Testing Market, by Sanger Sequencing, by Region, 2016- 2027 (USD Million)
  • 6.8. Karyotyping
    • 6.8.1. Global Rare Disease Genetic Testing Market, by Karyotyping, by Region, 2016- 2027 (USD Million)

7. Global Rare Disease Genetic Testing Market, by Specialty

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Rare Disease Genetic Testing Market, By Specialty, 2016 - 2027 (USD Million)
  • 7.3. Molecular Genetic Testing
    • 7.3.1. Global Rare Disease Genetic Testing Market, by Molecular, By Region, 2016- 2027 (USD Million)
  • 7.4. Chromosomal Genetic Testing
    • 7.4.1. Global Rare Disease Genetic Testing Market, by Chromosomal, by Region, 2016- 2027 (USD Million)
  • 7.5. Biochemical Genetic Tests
    • 7.5.1. Global Rare Disease Genetic Testing Market, by Biochemical Genetic Tests, by Region, 2016- 2027 (USD Million)

8. Rare Disease Genetic Testing Market Assessment by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Rare Disease Genetic Testing Market, By End Use, 2016 - 2027 (USD Million)
  • 8.3. Research Laboratories & CROs
    • 8.3.1. Global Rare Disease Genetic Testing Market, by Research Laboratories & CROs, by Region, 2016- 2027 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Global Rare Disease Genetic Testing Market, by Hospitals & Clinics, by Region, 2016- 2027 (USD Million)
  • 8.5. Diagnostic Laboratories
    • 8.5.1. Global Rare Disease Genetic Testing Market, by Diagnostic Laboratories, by Region, 2016- 2027 (USD Million)

9. Rare Disease Genetic Testing Market Assessment by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Rare Disease Genetic Testing Market Assessment, By Geography, 2016- 2027 (USD Million)
  • 9.3. Rare Disease Genetic Testing Market - North America
    • 9.3.1. North America: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.3.2. North America: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
    • 9.3.3. North America: Rare Disease Genetic Testing Market, By Specialty, 2016 - 2027 (USD Million)
    • 9.3.4. North America: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.3.5. Rare Disease Genetic Testing Market - U.S.
      • 9.3.5.1. U.S.: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.3.5.2. U.S.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.3.5.3. U.S.: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.3.5.4. U.S.: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.3.6. Rare Disease Genetic Testing Market - Canada
      • 9.3.6.1. Canada: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.3.6.2. Canada.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.3.6.3. Canada: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.3.6.4. Canada: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
  • 9.4. Rare Disease Genetic Testing Market - Europe
    • 9.4.1. Europe: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.4.2. Europe.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
    • 9.4.3. Europe: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
    • 9.4.4. Europe: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.4.5. Rare Disease Genetic Testing Market - UK
      • 9.4.5.1. UK: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.5.2. UK.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.4.5.3. UK: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.4.5.4. UK: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.4.6. Rare Disease Genetic Testing Market - France
      • 9.4.6.1. France: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.6.2. France.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.4.6.3. France: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.4.6.4. France: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.4.7. Rare Disease Genetic Testing Market - Germany
      • 9.4.7.1. Germany: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.7.2. Germany.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.4.7.3. Germany: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.4.7.4. Germany: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.4.8. Rare Disease Genetic Testing Market - Italy
      • 9.4.8.1. Italy: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.8.2. Italy.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.4.8.3. Italy: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.4.8.4. Italy: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.4.9. Rare Disease Genetic Testing Market - Spain
      • 9.4.9.1. Spain: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.9.2. Spain.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.4.9.3. Spain: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.4.9.4. Spain: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.4.10. Rare Disease Genetic Testing Market - Netherlands
      • 9.4.10.1. Netherlands: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.10.2. Netherlands.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.4.10.3. Netherlands: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.4.10.4. Netherlands: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.4.11. Rare Disease Genetic Testing Market - Austria
      • 9.4.11.1. Austria: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.11.2. Austria.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.4.11.3. Austria: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.4.11.4. Austria: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
  • 9.5. Rare Disease Genetic Testing Market - Asia-Pacific
    • 9.5.1. Asia Pacific: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.5.2. Asia Pacific.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
    • 9.5.3. Asia-pacific: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
    • 9.5.4. Asia-pacific: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.5.5. Rare Disease Genetic Testing Market - China
      • 9.5.5.1. China: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.5.2. China.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.5.5.3. China: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.5.5.4. China: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.5.6. Rare Disease Genetic Testing Market - India
      • 9.5.6.1. India: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.6.2. India.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.5.6.3. India: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.5.6.4. India: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.5.7. Rare Disease Genetic Testing Market - Malaysia
      • 9.5.7.1. Malaysia: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.7.2. Malaysia.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.5.7.3. Malaysia: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.5.7.4. Malaysia: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.5.8. Rare Disease Genetic Testing Market - Japan
      • 9.5.8.1. Japan: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.8.2. Japan.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.5.8.3. Japan: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.5.8.4. Japan: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.5.9. Rare Disease Genetic Testing Market - Indonesia
      • 9.5.9.1. Indonesia: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.9.2. Indonesia.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.5.9.3. Indonesia: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.5.9.4. Indonesia: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.5.10. Rare Disease Genetic Testing Market - South Korea
      • 9.5.10.1. South Korea: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.10.2. South Korea.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.5.10.3. South Korea: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.5.10.4. South Korea: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
  • 9.6. Rare Disease Genetic Testing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.6.2. Middle East & Africa.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
    • 9.6.3. Middle East & Africa: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
    • 9.6.4. Middle East & Africa: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.6.5. Rare Disease Genetic Testing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.6.5.2. Saudi Arabia.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.6.5.3. Saudi Arabia: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.6.5.4. Saudi Arabia: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.6.6. Rare Disease Genetic Testing Market - UAE
      • 9.6.6.1. UAE: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.6.6.2. UAE.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.6.6.3. UAE: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.6.6.4. UAE: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.6.7. Rare Disease Genetic Testing Market - Israel
      • 9.6.7.1. Israel: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.6.7.2. Israel.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.6.7.3. Israel: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.6.7.4. Israel: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.6.8. Rare Disease Genetic Testing Market - South Africa
      • 9.6.8.1. South Africa: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.6.8.2. South Africa.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.6.8.3. South Africa: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.6.8.4. South Africa: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
  • 9.7. Rare Disease Genetic Testing Market - Latin America
    • 9.7.1. Latin America: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.7.2. Latin America.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
    • 9.7.3. Latin America: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
    • 9.7.4. Latin America: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.7.5. Rare Disease Genetic Testing Market - Mexico
      • 9.7.5.1. Mexico: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.7.5.2. Mexico.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.7.5.3. Mexico: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.7.5.4. Mexico: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.7.6. Rare Disease Genetic Testing Market - Brazil
      • 9.7.6.1. Brazil: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.7.6.2. Brazil.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.7.6.3. Brazil: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.7.6.4. Brazil: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)
    • 9.7.7. Rare Disease Genetic Testing Market - Argentina
      • 9.7.7.1. Argentina: Rare Disease Genetic Testing Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.7.7.2. Argentina.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027 (USD Million)
      • 9.7.7.3. Argentina: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027 (USD Million)
      • 9.7.7.4. Argentina: Rare Disease Genetic Testing Market, By End Use, 2016- 2027 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Strand Life Sciences
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Services/Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Myriad Genetics
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Services/Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Quest Diagnostics Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Services/Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Centogene N.V.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Services/Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Invitae Corporation
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Services/Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Eurofins Scientific
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Services/Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Ambry Genetics
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Services/Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Macrogen, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Services/Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Health Network Laboratories
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Services/Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Fulgent Genetics Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Services/Product Benchmarking
    • 11.10.4. Recent Development

List of Tables

  • Table 1 Global Rare Disease Genetic Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 2 Global Rare Disease Genetic Testing Market, by Technology, by Region, 2016-2027 (USD Million)
  • Table 3 Global Rare Disease Genetic Testing Market, by Specialty, by Region, 2016-2027 (USD Million)
  • Table 4 Global Rare Disease Genetic Testing Market, by End Use, by Region, 2016-2027 (USD Million)
  • Table 5 Rare Disease Genetic Testing Market Assessment, By Geography, 2016-2027 (USD Million)
  • Table 6 North America: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 7 North America: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 8 North America: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 9 North America: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 10 U.S.: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 11 U.S.: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 12 U.S.: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 13 U.S.: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 14 Canada: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 15 Canada: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 16 Canada: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 17 Canada: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 18 Europe: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 19 Europe: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 20 Europe: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 21 Europe: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 22 UK: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 23 UK: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 24 UK: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 25 UK: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 26 France: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 27 France: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 28 France: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 29 France: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 30 Germany: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 31 Germany: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 32 Germany: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 33 Germany: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 34 Italy: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 35 Italy: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 36 Italy: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 37 Italy: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 38 Netherlands: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 39 Netherlands: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 40 Netherlands: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 41 Netherlands: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 42 Austria: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 43 Austria: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 44 Austria: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 45 Austria: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 46 Asia Pacific: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 47 Asia Pacific: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 48 Asia Pacific: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 49 Asia Pacific: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 50 China: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 51 China: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 52 China: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 53 China: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 54 India: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 55 India: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 56 India: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 57 India: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 58 Japan: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 59 Japan: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 60 Japan: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 61 Japan: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 62 Malaysia: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 63 Malaysia: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 64 Malaysia: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 65 Malaysia: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 66 Indonesia: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 67 Indonesia: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 68 Indonesia: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 69 Indonesia: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 70 South Korea: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 71 South Korea: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 72 South Korea: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 73 South Korea: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 74 Middle East & Africa: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 75 Middle East & Africa: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 76 Middle East & Africa: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 77 Middle East & Africa: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 78 Saudi Arabia: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 79 Saudi Arabia: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 80 Saudi Arabia: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 81 Saudi Arabia: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 82 Israel: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 83 Israel: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 84 Israel: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 85 Israel: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 86 South Africa: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 87 South Africa: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 88 South Africa: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 89 South Africa: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 90 Latin America: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 91 Latin America: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 92 Latin America: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 93 Latin America: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 94 Brazil: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 95 Brazil: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 96 Brazil: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 97 Brazil: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 98 Mexico: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 99 Mexico: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 100 Mexico: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 101 Mexico: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)
  • Table 102 Argentina: Rare Disease Genetic Testing Market, By Disease Type, 2016-2027 (USD Million)
  • Table 103 Argentina: Rare Disease Genetic Testing Market, By Technology, 2016-2027 (USD Million)
  • Table 104 Argentina: Rare Disease Genetic Testing Market, By Specialty, 2016-2027 (USD Million)
  • Table 105 Argentina: Rare Disease Genetic Testing Market, By End Use, 2016-2027 (USD Million)

List of Figures

Figure 1. Global Rare Disease Genetic Testing Market, By Disease Type, 2016 - 2027 (USD Million)

Figure 2. Integrated Ecosystem

Figure 3. Global Rare Disease Genetic Testing Market, by Specialty , by Region, 2016-2027 (USD Million)

Figure 4. Market by Geography

Figure 6. Porter's Five Forces

Figure 7. Market by Disease Type

Figure 8. Global Rare Disease Genetic Testing Market, By Disease Type, 2019 & 2027 (USD Million)

Figure 9. Market by Technology

Figure 8. Global Rare Disease Genetic Testing Market, By Technology, 2019 & 2027 (USD Million)

Figure 9. Market by Specialty

Figure 10. Global Rare Disease Genetic Testing Market, By Specialty, 2019 & 2027 (USD Million)

Figure 11. Market by End Use

Figure 12. Global Rare Disease Genetic Testing Market, By End Use, 2019 & 2027 (USD Million)

Figure 13. Rare Disease Genetic Testing Market Assessment, By Geography, 2016-2027 (USD Million)

Figure 14. Strategic Analysis - Rare Disease Genetic Testing Market